Hyperuricemia and cardiovascular risk: gut microbiota as a key link in pathogenesis and a new target for therapy

Read full text Summarise with VIRAT
Authors: E.V. Reznik, Л.Х. Алиева, V. A. Fefelova, Lyudmila I. Kafarskaia
Cited by: 0
References: 40

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Hyperuricemia is a significant and independent risk factor for cardiovascular diseases. In recent years, scientists have been paying attention to the gut microbiota and its impact on various processes in the human body. Currently, there is evidence of the important role of the microbiota in the pathogenesis of hyperuricemia. An increase in the number of pathogenic microflora contributes to chronic inflammation and an increase in uric acid levels through the mechanisms of purine metabolism. The purpose of this review is to analyze and systematize current data on the impact of the intestinal microbiota on the pathogenesis of hyperuricemia and cardiovascular risk. The article discusses promising methods for correcting hyperuricemia, such as lifestyle modification, fecal microbiota transplantation, probiotics, and postbiotics. The review highlights the need for further research on the microbiota as a key factor in the pathogenesis of hyperuricemia and the development of new and innovative therapeutic strategies.

Fields of Study & Subjects

Gout Hyperuricemia Uric Acid Gut microbiota and health Diet Metabolism and Disease

Publication details

Journal / source
The Russian Archives of Internal Medicine
Volume
16
Issue
2
Pages
104–112
Publication date
28 March 2026
Language
EN